Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HDM3010 in adults with prurigo nodularis
CTR20250179Phase 2Active
- Sponsor
- 杭州中美华东制药有限公司 (Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.)
- Start
- Feb 2025
- Countries
- 1
01
Overview
A Phase 2 trial of HDM3010 in prurigo nodularis (PN), sponsored by 杭州中美华东制药有限公司 (Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.). Started Feb 2025; status: active.
02
Drugs
HDM3010
03
Conditions
prurigo nodularis (PN)
Beyond the preview
Go deeper on CTR20250179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250179.